Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

The company emphasized its commitment to data privacy ... Regeneron umbrella, with more information about post-deal operations to be shared once the transaction is finalized. Joe Selsavage ...

The company’s co-founder and CEO ... Regeneron emphasized that it sees significant value in preserving and expanding 23andMe’s core mission of empowering individuals through genetic insights.

Its co-founder and CEO ... Regeneron co-founder, board co-chair and Chief Scientific Officer George Yancopoulos said in a statement. Regeneron said Monday that it will comply with 23andMe’s ...